Â¥
13.77
May 13
New Key Statistics Module, Z-Score and F-Score
SZSE:002019 Key Ratios
Market Cap ¥ M | 16,882.36 |
Enterprise Value ¥ M | 18,157.21 |
P/E(ttm) | -- |
PE Ratio without NRI | 35.67 |
Forward PE Ratio | -- |
Price/Book | 2.01 |
Price/Sales | 3.77 |
Price/Free Cash Flow | 1,377.00 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 4,455.00 |
EPS (TTM) ¥ | -0.38 |
Beneish M-Score | -2.8 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -563.30 |
EV-to-EBIT | -26.61 |
EV-to-EBITDA | -26.61 |
PEG | -- |
Shares Outstanding M | 1,226.02 |
Net Margin (%) | -10.54 |
Operating Margin % | 6.42 |
Pre-tax Margin (%) | -16.95 |
Quick Ratio | 1.03 |
Current Ratio | 1.43 |
ROA % (ttm) | -3.86 |
ROE % (ttm) | -5.40 |
ROIC % (ttm) | 2.97 |
Dividend Yield % | -- |
Altman Z-Score | 3.79 |
SZSE:002019 Number of Guru Trades
SZSE:002019 Volume of Guru Trades
Gurus Latest Trades with SZSE:002019
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002019 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
YIFAN PHARMACEUTICAL CO LTD Insider Transactions
No Available Data